Futura Medical PLC (LSE: FUM) is a UK-based pharmaceutical company focused on the development and commercialisation of innovative, fast-acting topical treatments. Its flagship product, Eroxon®, is a clinically proven treatment for erectile dysfunction, available without prescription. With strong clinical data, global regulatory approvals, and commercial partnerships, Futura is bringing novel consumer health products to market.
最新股票文章
日元走势预测：第三方价格目标
2025年截至目前，美元兑日元（USD/JPY）汇率年内下跌约9.41%。 2025年4月25日，日元兑美元收于142.8790，创下自2024年9月以来的最强水平之一，较2024年7月的高点161.942下跌约11.77%。
14:34, 19 六月 2025
评分与评论
评分与评论
